Journal of Pharmacogenomics & Pharmacoproteomics follows a double-blind peer review system. The reviewer does not know the identity of the author, and the author does not know the identity of the reviewer. There are at least three or more reviewers for the total number of articles in each issue. The magazine is intended for publication by clinical, medical or health professionals, students, professionals and researchers, as well as professional groups and institutions.
Every submitted manuscript managed for preliminary quality control check through editorial office followed by external peer review process. Usually preliminary quality control completes within 7 days and remains majorly with reference to journal formatting, English and journal scope.